BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wolf ME, Luz B, Niehaus L, Bhogal P, Bäzner H, Henkes H. Thrombocytopenia and Intracranial Venous Sinus Thrombosis after "COVID-19 Vaccine AstraZeneca" Exposure. J Clin Med 2021;10:1599. [PMID: 33918932 DOI: 10.3390/jcm10081599] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 24.0] [Reference Citation Analysis]
Number Citing Articles
1 Abrignani MG, Murrone A, De Luca L, Roncon L, Di Lenarda A, Valente S, Caldarola P, Riccio C, Oliva F, Gulizia MM, Gabrielli D, Colivicchi F, On Behalf Of The Working Group On Anti-Covid-Vaccination Of The Associazione Nazionale Medici Cardiologi Ospedalieri Anmco. COVID-19, Vaccines, and Thrombotic Events: A Narrative Review. J Clin Med 2022;11:948. [PMID: 35207220 DOI: 10.3390/jcm11040948] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Li X, To KK, Yuen K. Variants of SARS Coronavirus-2 and Their Potential Impact on the Future of the COVID-19 Pandemic. Zoonoses 2021;1. [DOI: 10.15212/zoonoses-2021-1003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Elberry MH, Abdelgawad HAH, Hamdallah A, Abdella WS, Ahmed AS, Ghaith HS, Negida A. A systematic review of vaccine-induced thrombotic thrombocytopenia in individuals who received COVID-19 adenoviral-vector-based vaccines. J Thromb Thrombolysis. [DOI: 10.1007/s11239-021-02626-w] [Reference Citation Analysis]
4 Abbattista M, Martinelli I, Peyvandi F. Comparison of adverse drug reactions among four COVID-19 vaccines in Europe using the EudraVigilance database: Thrombosis at unusual sites. J Thromb Haemost 2021. [PMID: 34375510 DOI: 10.1111/jth.15493] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Arepally GM, Ortel TL. Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know. Blood 2021;138:293-8. [DOI: 10.1182/blood.2021012152] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
6 Ahmed SH, Shaikh TG, Waseem S, Qadir NA, Yousaf Z, Ullah I. Vaccine-induced thrombotic thrombocytopenia following coronavirus vaccine: A narrative review. Ann Med Surg (Lond) 2021;:102988. [PMID: 34745596 DOI: 10.1016/j.amsu.2021.102988] [Reference Citation Analysis]
7 Chakraborty C, Sharma AR, Bhattacharya M, Lee SS. Lessons Learned from Cutting-Edge Immunoinformatics on Next-Generation COVID-19 Vaccine Research. Int J Pept Res Ther 2021;:1-9. [PMID: 34276266 DOI: 10.1007/s10989-021-10254-4] [Reference Citation Analysis]
8 Lin W, Ko CA, Sung YF, Chen YC, Lee JT, Lin YQ, Lin YK. Cerebral Venous Sinus Thrombosis, Pulmonary Embolism, and Thrombocytopenia After COVID-19 Vaccination in a Taiwanese Man: A Case Report and Literature Review. Front Neurol 2021;12:738329. [PMID: 34630307 DOI: 10.3389/fneur.2021.738329] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Barranco R, Rocca G, Molinelli A, Ventura F. Controversies and Challenges of Mass Vaccination against SARS-CoV-2 in Italy: Medico-Legal Perspectives and Considerations. Healthcare (Basel) 2021;9:1163. [PMID: 34574937 DOI: 10.3390/healthcare9091163] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Lentzen MP, Huebenthal V, Kaiser R, Kreppel M, Zoeller JE, Zirk M. A retrospective analysis of social media posts pertaining to COVID-19 vaccination side effects. Vaccine 2022;40:43-51. [PMID: 34857421 DOI: 10.1016/j.vaccine.2021.11.052] [Reference Citation Analysis]
11 Cazzato G, Romita P, Foti C, Cimmino A, Colagrande A, Arezzo F, Sablone S, Barile A, Lettini T, Resta L, Ingravallo G. Purpuric Skin Rash in a Patient Undergoing Pfizer-BioNTech COVID-19 Vaccination: Histological Evaluation and Perspectives. Vaccines (Basel) 2021;9:760. [PMID: 34358176 DOI: 10.3390/vaccines9070760] [Reference Citation Analysis]
12 Finsterer J, Zarrouk S. Post-SARS-CoV-2 vaccination venous sinus thrombosis: a literature review of 308 cases. Egypt J Neurol Psychiatr Neurosurg 2021;57:179. [PMID: 34955632 DOI: 10.1186/s41983-021-00431-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Althaus K, Möller P, Uzun G, Singh A, Beck A, Bettag M, Bösmüller H, Guthoff M, Dorn F, Petzold GC, Henkes H, Heyne N, Jumaa H, Kreiser K, Limpach C, Luz B, Maschke M, Müller JA, Münch J, Nagel S, Pötzsch B, Müller J, Schlegel C, Viardot A, Bäzner H, Wolf M, Pelzl L, Warm V, Willinek WA, Steiner J, Schneiderhan-Marra N, Vollherbst D, Sachs UJ, Fend F, Bakchoul T. Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia. Haematologica 2021;106:2170-9. [PMID: 34011137 DOI: 10.3324/haematol.2021.279000] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
14 Belopasov VV, Zhuravleva EN, Nugmanova NP, Abdrashitova AT. Post-covid-19 neurological syndromes. Journal of Clinical Practice 2021;12:69-82. [DOI: 10.17816/clinpract71137] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Choi PY, Grace RF, Therese Ahlen M, Nazy I, Sachs UJ, Arnold DM, McKenzie SE, Althaus K, Sharma R, Bakchoul T. The SSC platelet immunology register of VITT and VIITP: Toward standardization of laboratory and clinical parameters. J Thromb Haemost 2021;19:2094-5. [PMID: 34076338 DOI: 10.1111/jth.15402] [Reference Citation Analysis]
16 Violi F, Cammisotto V, Pastori D, Pignatelli P. Thrombosis in pre- and post-vaccination phase of COVID-19. Eur Heart J Suppl 2021;23:E184-8. [PMID: 34650382 DOI: 10.1093/eurheartj/suab118] [Reference Citation Analysis]
17 Myllylahti L, Pitkänen H, Magnani H, Lassila R. Experience of danaparoid to treat vaccine-induced immune thrombocytopenia and thrombosis, VITT. Thromb J 2022;20:4. [PMID: 35120527 DOI: 10.1186/s12959-021-00362-y] [Reference Citation Analysis]
18 Sharifian-Dorche M, Bahmanyar M, Sharifian-Dorche A, Mohammadi P, Nomovi M, Mowla A. Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review. J Neurol Sci 2021;428:117607. [PMID: 34365148 DOI: 10.1016/j.jns.2021.117607] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Jones M, Boisvert A, Landry J, Petrasek PF. Limb ischemia and pulmonary artery thrombosis afer the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine: a case of vaccine-induced immune thrombotic thrombocytopenia. CMAJ 2021:cmaj. [PMID: 33990339 DOI: 10.1503/cmaj.210795] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Novak N, Tordesillas L, Cabanillas B. Adverse rare events to vaccines for COVID-19: From hypersensitivity reactions to thrombosis and thrombocytopenia. Int Rev Immunol 2021;:1-10. [PMID: 34251972 DOI: 10.1080/08830185.2021.1939696] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Waqar U, Ahmed S, Gardezi SMHA, Tahir MS, Abidin ZU, Hussain A, Ali N, Mahmood SF. Thrombosis with Thrombocytopenia Syndrome After Administration of AZD1222 or Ad26.COV2.S Vaccine for COVID-19: A Systematic Review. Clin Appl Thromb Hemost 2021;27:10760296211068487. [PMID: 34907794 DOI: 10.1177/10760296211068487] [Reference Citation Analysis]
22 Pang E, Ghosh S, Chemmanam T, Grove C, Phillips T. Cerebral arterial and venous thrombosis due to COVID-19 vaccine-induced immune thrombotic thrombocytopenia. BMJ Case Rep 2022;15:e245445. [DOI: 10.1136/bcr-2021-245445] [Reference Citation Analysis]
23 Hwang SE, Kim WH, Heo J. Socio-demographic, psychological, and experiential predictors of COVID-19 vaccine hesitancy in South Korea, October-December 2020. Hum Vaccin Immunother 2021;:1-8. [PMID: 34614382 DOI: 10.1080/21645515.2021.1983389] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Singh A, Toma F, Uzun G, Wagner TR, Pelzl L, Zlamal J, Freytag V, Weich K, Nowak-Harnau S, Rothbauer U, Althaus K, Bakchoul T. The interaction between anti-PF4 antibodies and anticoagulants in vaccine-induced thrombotic thrombocytopenia. Blood 2022;139:3430-8. [PMID: 35679071 DOI: 10.1182/blood.2021013839] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Mohamed Hussein AAR, Ibrahim IH, Mahmoud IA, Amary M, Sayad R. To what extent AstraZeneca ChAdOx1 nCoV-19 vaccine is safe and effective? Rapid systematic review. Egypt J Bronchol 2022;16. [DOI: 10.1186/s43168-021-00109-3] [Reference Citation Analysis]
26 Cimolai N. Untangling the Intricacies of Infection, Thrombosis, Vaccination, and Antiphospholipid Antibodies for COVID-19. SN Compr Clin Med 2021;:1-16. [PMID: 34179695 DOI: 10.1007/s42399-021-00992-3] [Reference Citation Analysis]
27 Pomara C, Salerno M, Esposito M, Sessa F, Certo F, Tripodo C, Rappa F, Barbagallo GM. Histological and immunohistochemical findings in a fatal case of thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. Pathology - Research and Practice 2022;231:153796. [DOI: 10.1016/j.prp.2022.153796] [Reference Citation Analysis]
28 Kakovan M, Shirkouhi SG, Zarei M, Andalib S. Stroke Associated with COVID-19 Vaccines. Journal of Stroke and Cerebrovascular Diseases 2022. [DOI: 10.1016/j.jstrokecerebrovasdis.2022.106440] [Reference Citation Analysis]
29 Mani A, Ojha V. Thromboembolism after Covid-19 vaccination: a systematic review of such events in 286 patients. Ann Vasc Surg 2022:S0890-5096(22)00219-9. [PMID: 35568325 DOI: 10.1016/j.avsg.2022.05.001] [Reference Citation Analysis]
30 Sriwastava S, Shrestha AK, Khalid SH, Colantonio MA, Nwafor D, Srivastava S. Spectrum of Neuroimaging Findings in Post-COVID-19 Vaccination: A Case Series and Review of Literature. Neurol Int 2021;13:622-39. [PMID: 34842783 DOI: 10.3390/neurolint13040061] [Reference Citation Analysis]
31 Mücke VT, Knop V, Mücke MM, Ochsendorf F, Zeuzem S. First description of immune complex vasculitis after COVID-19 vaccination with BNT162b2: a case report. BMC Infect Dis 2021;21:958. [PMID: 34530771 DOI: 10.1186/s12879-021-06655-x] [Reference Citation Analysis]
32 Mohseni Afshar Z, Babazadeh A, Janbakhsh A, Afsharian M, Saleki K, Barary M, Ebrahimpour S. Vaccine-induced immune thrombotic thrombocytopenia after vaccination against Covid-19: A clinical dilemma for clinicians and patients. Rev Med Virol 2021;:e2273. [PMID: 34197678 DOI: 10.1002/rmv.2273] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Shahgolzari M, Yavari A, Arjeini Y, Miri SM, Darabi A, Mozaffari Nejad AS, Keshavarz M. Immunopathology and Immunopathogenesis of COVID-19, what we know and what we should learn. Gene Rep 2021;25:101417. [PMID: 34778602 DOI: 10.1016/j.genrep.2021.101417] [Reference Citation Analysis]
34 Rijkers GT, Weterings N, Obregon-Henao A, Lepolder M, Dutt TS, van Overveld FJ, Henao-Tamayo M. Antigen Presentation of mRNA-Based and Virus-Vectored SARS-CoV-2 Vaccines. Vaccines (Basel) 2021;9:848. [PMID: 34451973 DOI: 10.3390/vaccines9080848] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
35 Wilting FNH, Kotsopoulos AMM, Platteel ACM, van Oers JAH. Intracerebral Hemorrhage and Thrombocytopenia After AstraZeneca COVID-19 Vaccine: Clinical and Diagnostic Challenges of Vaccine-Induced Thrombotic Thrombocytopenia. Cureus 2021;13:e17637. [PMID: 34646685 DOI: 10.7759/cureus.17637] [Reference Citation Analysis]
36 Fervers P, Kottlors J, Persigehl T, Lennartz S, Maus V, Fischer S, Styczen H, Deuschl C, Schlamann M, Mpotsaris A, Zubel S, Schroeter M, Maintz D, Fink GR, Abdullayev N. Meaningful use of imaging resources to rule out cerebral venous sinus thrombosis after ChAdOx1 COVID-19 vaccination: Evaluation of the AHA diagnostic algorithm with a clinical cohort and a systematic data review. Journal of Clinical Neuroscience 2022;102:5-12. [DOI: 10.1016/j.jocn.2022.05.031] [Reference Citation Analysis]
37 Ornelas-aguirre JM, Gómez-alcalá AV, Ramírez-leyva DH. Increment of D-dimer Associated with Immune Thrombotic Thrombocytopenia in ChAdOx1 nCoV-19 (AstraZeneca-Oxford) Vaccinated Individuals: A Systematic Review. Archives of Medical Research 2022. [DOI: 10.1016/j.arcmed.2022.03.008] [Reference Citation Analysis]
38 Beeraka NM, Sukocheva OA, Lukina E, Liu J, Fan R. Development of antibody resistance in emerging mutant strains of SARS CoV-2: Impediment for COVID-19 vaccines. Rev Med Virol 2022;:e2346. [PMID: 35416390 DOI: 10.1002/rmv.2346] [Reference Citation Analysis]
39 Alghamdi A, Ibrahim A, Almutairi R, Joseph M, Alghamdi G, Alhamza A. A cross-sectional survey of side effects after COVID-19 vaccination in Saudi Arabia: male versus female outcomes. J Adv Pharm Educ Res 2021;11:51-6. [DOI: 10.51847/bcwca2qgfp] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
40 Marfe G, Perna S, Shukla AK. Effectiveness of COVID-19 vaccines and their challenges (Review). Exp Ther Med 2021;22:1407. [PMID: 34676000 DOI: 10.3892/etm.2021.10843] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Jones M, Boisvert A, Landry J, Petrasek PF. Ischémie d’un membre et thrombose de l’artère pulmonaire après l’administration du vaccin ChAdOx1 nCoV-19 (Oxford–AstraZeneca) : un cas de thrombocytopénie thrombotique immunitaire induite par le vaccin. CMAJ 2021;193:E1021-6. [PMID: 34226271 DOI: 10.1503/cmaj.210795-f] [Reference Citation Analysis]
42 Palaiodimou L, Stefanou MI, Katsanos AH, Aguiar de Sousa D, Coutinho JM, Lagiou P, Michopoulos I, Naska A, Giannopoulos S, Vadikolias K, Voumvourakis KI, Papaevangelou V, Vassilakopoulos TI, Tsiodras S, Tsivgoulis G. Cerebral Venous Sinus Thrombosis and Thrombotic Events After Vector-Based COVID-19 Vaccines: A Systematic Review and Meta-analysis. Neurology 2021;97:e2136-47. [PMID: 34610990 DOI: 10.1212/WNL.0000000000012896] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
43 Tomassini L, Paolini D, Petrasso PEY, Maria Manta A, Piersanti V, Straccamore M, Ciallella C. What about cerebral venous sinus thrombosis? A series of three autopsy cases. Legal Medicine 2022. [DOI: 10.1016/j.legalmed.2022.102052] [Reference Citation Analysis]
44 Scutelnic A, Brodard J, Kremer Hovinga JA, Arnold M, Heldner MR. Cerebral Venous Sinus Thrombosis Associated with Vaccine-Induced Thrombotic Thrombocytopenia—A Narrative Review. CTN 2022;6:11. [DOI: 10.3390/ctn6020011] [Reference Citation Analysis]
45 Cau R, Mantini C, Monti L, Mannelli L, Di Dedda E, Mahammedi A, Nicola R, Roubil J, Suri JS, Cerrone G, Fanni D, Faa G, Carriero A, Scuteri A, Francone M, Saba L. Role of imaging in rare COVID-19 vaccine multiorgan complications. Insights Imaging 2022;13. [DOI: 10.1186/s13244-022-01176-w] [Reference Citation Analysis]
46 Jolobe OMP. Extending the clinical spectrum of thrombotic thrombocytopenic syndrome attributable to adenovirus-based vaccines for Covid-19. Am J Emerg Med 2021:S0735-6757(21)00437-X. [PMID: 34059386 DOI: 10.1016/j.ajem.2021.05.053] [Reference Citation Analysis]
47 Lee YK, Huang YH. Ocular Manifestations after Receiving COVID-19 Vaccine: A Systematic Review. Vaccines (Basel) 2021;9:1404. [PMID: 34960150 DOI: 10.3390/vaccines9121404] [Reference Citation Analysis]
48 Iheanacho CO, Eze UIH. Immunogenicity and clinical features relating to BNT162b2 messenger RNA COVID-19 vaccine, Ad26.COV2.S and ChAdOx1 adenoviral vector COVID-19 vaccines: a systematic review of non-interventional studies. Futur J Pharm Sci 2022;8:20. [PMID: 35368622 DOI: 10.1186/s43094-022-00409-5] [Reference Citation Analysis]
49 Pomara C, Sessa F, Ciaccio M, Dieli F, Esposito M, Giammanco GM, Garozzo SF, Giarratano A, Prati D, Rappa F, Salerno M, Tripodo C, Mannucci PM, Zamboni P. COVID-19 Vaccine and Death: Causality Algorithm According to the WHO Eligibility Diagnosis. Diagnostics (Basel) 2021;11:955. [PMID: 34073536 DOI: 10.3390/diagnostics11060955] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
50 Choi JK, Kim S, Kim SR, Jin JY, Choi SW, Kim H, Yoo JH, Park IS, Kim SR. Intracerebral Hemorrhage due to Thrombosis with Thrombocytopenia Syndrome after Vaccination against COVID-19: the First Fatal Case in Korea. J Korean Med Sci 2021;36:e223. [PMID: 34402235 DOI: 10.3346/jkms.2021.36.e223] [Reference Citation Analysis]
51 Thiele T, Weisser K, Schönborn L, Funk MB, Weber G, Greinacher A, Keller-Stanislawski B. Laboratory confirmed vaccine-induced immune thrombotic thrombocytopenia: Retrospective analysis of reported cases after vaccination with ChAdOx-1 nCoV-19 in Germany. Lancet Reg Health Eur 2022;12:100270. [PMID: 34901912 DOI: 10.1016/j.lanepe.2021.100270] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
52 Hwang J, Park SH, Lee SW, Lee SB, Lee MH, Jeong GH, Kim MS, Kim JY, Koyanagi A, Jacob L, Jung SY, Song J, Yon DK, Shin JI, Smith L. Predictors of mortality in thrombotic thrombocytopenia after adenoviral COVID-19 vaccination: the FAPIC score. Eur Heart J 2021;42:4053-63. [PMID: 34545400 DOI: 10.1093/eurheartj/ehab592] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
53 Al-Ali D, Elshafeey A, Mushannen M, Kawas H, Shafiq A, Mhaimeed N, Mhaimeed O, Mhaimeed N, Zeghlache R, Salameh M, Paul P, Homssi M, Mohammed I, Narangoli A, Yagan L, Khanjar B, Laws S, Elshazly MB, Zakaria D. Cardiovascular and haematological events post COVID-19 vaccination: A systematic review. J Cell Mol Med 2021. [PMID: 34967105 DOI: 10.1111/jcmm.17137] [Reference Citation Analysis]
54 Sultana A, Shahriar S, Tahsin MR, Mim SR, Fatema KR, Saha A, Yesmin F, Bahar NB, Samodder M, Mamun MAH, Aknur Rahman M, Ferdousy S, Akter T, Aktar F, Kuddus MR, Rahman MM, Sarker MMR, Büyüker SM, Chowdhury JA, Chowdhury AA, Kabir S, Hossain MA, Amran MS. A Retrospective Cross-Sectional Study Assessing Self-Reported Adverse Events following Immunization (AEFI) of the COVID-19 Vaccine in Bangladesh. Vaccines (Basel) 2021;9:1090. [PMID: 34696198 DOI: 10.3390/vaccines9101090] [Reference Citation Analysis]
55 Sachs UJ, Cooper N, Czwalinna A, Müller J, Pötzsch B, Tiede A, Althaus K. PF4-Dependent Immunoassays in Patients with Vaccine-Induced Immune Thrombotic Thrombocytopenia: Results of an Interlaboratory Comparison. Thromb Haemost 2021. [PMID: 34169493 DOI: 10.1055/a-1535-9002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
56 Al-ansari RY, Al Qahtany FH, Qomawi Y, Fadoul T, Woodman A. Severe thrombocytopenia after Vaxzevria vaccination in a single patient: A case report. SAGE Open Medical Case Reports 2022;10:2050313X2210914. [DOI: 10.1177/2050313x221091407] [Reference Citation Analysis]
57 Umbrello M, Brena N, Vercelli R, Foa RA, Femia M, Rossi U, Podda GM, Cortellaro F, Muttini S. Successful treatment of acute spleno-porto-mesenteric vein thrombosis after ChAdOx1 nCoV-19 vaccine. A case report. J Crit Care 2021;65:72-5. [PMID: 34111682 DOI: 10.1016/j.jcrc.2021.05.021] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
58 Lai CC, Ko WC, Chen CJ, Chen PY, Huang YC, Lee PI, Hsueh PR. COVID-19 vaccines and thrombosis with thrombocytopenia syndrome. Expert Rev Vaccines 2021;:1-9. [PMID: 34176415 DOI: 10.1080/14760584.2021.1949294] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
59 Cleaver J, Ibitoye R, Morrison H, Flood R, Crewdson K, Marsh A, Abhinav K, Bosnell R, Crossley R, Mortimer A. Endovascular treatment for vaccine-induced cerebral venous sinus thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccination: a report of three cases. J Neurointerv Surg 2021:neurintsurg-2021-018238. [PMID: 34782400 DOI: 10.1136/neurintsurg-2021-018238] [Reference Citation Analysis]
60 Siegler JE, Klein P, Yaghi S, Vigilante N, Abdalkader M, Coutinho JM, Abdul Khalek F, Nguyen TN. Cerebral Vein Thrombosis With Vaccine-Induced Immune Thrombotic Thrombocytopenia. Stroke 2021;52:3045-53. [PMID: 34304601 DOI: 10.1161/STROKEAHA.121.035613] [Reference Citation Analysis]
61 Wang RL, Chiang WF, Shyu HY, Chen MH, Lin CI, Wu KA, Yang CC, Huang LY, Hsiao PJ. COVID-19 vaccine-associated acute cerebral venous thrombosis and pulmonary artery embolism. QJM 2021:hcab185. [PMID: 34247246 DOI: 10.1093/qjmed/hcab185] [Reference Citation Analysis]
62 Jacków-Nowicka J, Jagiełło J, Dziadkowiak E, Bladowska J, Sąsiadek M, Zimny A. Acute cerebral venous thrombosis - still an underdiagnosed pathology in emergency computed tomography of the brain. Pol J Radiol 2021;86:e574-82. [PMID: 34876938 DOI: 10.5114/pjr.2021.109490] [Reference Citation Analysis]
63 Nohl A, Brune B, Weichert V, Standl F, Stang A, Dudda M. COVID-19: Vaccination Side Effects and Sick Leave in Frontline Healthcare-Workers—A Web-Based Survey in Germany. Vaccines 2022;10:411. [DOI: 10.3390/vaccines10030411] [Reference Citation Analysis]
64 Thakur KT, Tamborska A, Wood GK, McNeill E, Roh D, Akpan IJ, Miller EC, Bautista A, Claassen J, Kim CY, Guekht A, Pardo CA, Williams O, García-Azorín D, Prasad K, Schmutzhard E, Michael BD, Chou SH, Winkler AS, Solomon T, Elkind MS. Clinical review of cerebral venous thrombosis in the context of COVID-19 vaccinations: Evaluation, management, and scientific questions. J Neurol Sci 2021;427:117532. [PMID: 34134058 DOI: 10.1016/j.jns.2021.117532] [Reference Citation Analysis]